PBM
Psyence Biomedical Ltd.
NASDAQ · Healthcare · Biotechnology · CA
$4.12
−2.37%Sep 23, 2026, 19:56 UTC
Psyence Biomedical Ltd. announced a share-for-share exchange with Psyence Labs Ltd. alongside a $5 million cash investment to advance its U.S. ibogaine program.
Source:Sep 14, 2026, 23:48 UTC
Psyence Biomedical Ltd. announced the formation of Texas Ibogaine Research Corporation, a Texas-based U.S. vehicle to coordinate its ibogaine development activities including supply, regulatory engagement and potential clinical development.
Source:Jun 3, 2026, 00:00 UTC
Psyence Labs Ltd. disclosed a 30.1% stake in Psyence Biomedical Ltd. via a 13D/G filing.